Skip to content

REST: Reducing End-of-Life Symptoms With Touch

Efficacy of Massage at the End of Life

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00065195
Enrollment
440
Registered
2003-07-21
Start date
2003-11-30
Completion date
2007-03-31
Last updated
2008-01-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neoplasms, Pain

Keywords

Massage, Palliative Care, Hospices, Cancer

Brief summary

The purpose of this study is to determine whether massage therapy is effective in reducing pain and distress and improving quality of life among cancer patients at life's end.

Detailed description

Relieving physical and emotional symptoms is a key component of end-of-life care. Despite care, terminally ill patients are still significantly burdened by unrelieved symptoms. Therapies that have potential to alleviate these symptoms deserve thorough investigation. This study will last 3 weeks. Participants in this study will be randomly assigned to receive six sessions of either moving or nonmoving touch therapy, in addition to usual hospice care, for 2 weeks. Moving touch therapy consists of massage therapy in which a trained therapist continually touches a person's body. The nonmoving touch therapy will be conducted by volunteers who have no previous experience in massage. Participants in this group will have a volunteer rub specific body parts for 3-minute intervals. Because current evidence suggests that thoughts of healing may influence the effectiveness of touch therapy, volunteers in the nonmoving therapy group will distract their minds to avoid thinking of healing processes. In both groups, the person administering the touch therapy will note all interruptions during a session, including talk, music, and television. Interviews about medication use, pain, and quality of life will be used to assess participants; these interviews will be conducted at study start, immediately before and after each therapy session, and at Weeks 1, 2, and 3.

Interventions

PROCEDUREMoving touch therapy
PROCEDURENonmoving touch therapy

Sponsors

National Center for Complementary and Integrative Health (NCCIH)
Lead SponsorNIH

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Advanced cancer, with at least moderate pain 1 week prior to study entry * Life expectancy of at least 3 weeks * Able to speak English

Exclusion criteria

* Massage therapy within 1 month prior to study entry * Current use of anticoagulants * Platelet count less than 10,000 * Unstable spine that would interfere with touch therapy

Design outcomes

Primary

MeasureTime frame
Decreased pain

Secondary

MeasureTime frame
Less total analgesic medication use.
Improved quality of life
Decreased physical symptom distress
Decreased emotional symptom distress

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026